Trending
- African Energy 2024: Surging investment, waves of change
- AIM Congress 2025: Competition opens doors for Africa’s top tech innovators
- Zimbabwe rolls out $24M project to reduce use of mercury in gold mines
- Zambia secures $184M IMF support as economic growth set to decline to 1.2 per cent
- Equity enters alliance with ODDO BHF to spur Europe-Africa investments
- Air Tanzania hits turbulence: Can the airline fly back to EU skies?
- Ghana’s President Elect John Mahama Outlines His Economic Blueprint
- AfDB backs “green shares” funding model with $30M AFC equity boost
Browsing: Mpox vaccine
- Statistics show that the spread of mpox continues to worsen in Africa with over 2,500 new cases recorded in the last week alone.
- Epicentres the DRC and Burundi account for 86.7% of all new confirmed cases reported during the past week.
- To counter the disease spread, partners are supplying vaccines to nine hard-hit countries.
Mpox outbreak is reportedly worsening in Africa as the number of cases crossed 50,000 mark, the Africa Centers for Disease Control and Prevention (Africa CDC) has warned.
The threat was announced at a media brief on Thursday by Africa CDC Director-General Jean Kaseya, who highlighted that 19 African countries have reported 50,840 mpox cases, with 10,741 confirmed and 1,083 deaths since the start of this year.
“During last week alone, the continent reported 2,532 new cases, including 345 confirmed cases and 32 new deaths,” he reported.
According to the CDC Director-General, data from …
- WHO’s move aims to galvanize a coordinated international response to contain and mitigate the spread of mpox.
- An uptick in cases, especially in Burundi, Kenya, Uganda, and Rwanda, along with sporadic cases in Europe, prompted the WHO’s emergency declaration.
- Despite these concerns, mpox is not likely to evolve into a pandemic akin to COVID-19.
Last week, the World Health Organization (WHO) declared mpox (formerly known as monkeypox) a Public Health Emergency of International Concern. This decision underscores the escalating threat posed by the virus, which surged globally in 2022 but has since seen a troubling resurgence, particularly in Africa. The WHO’s move aims to galvanize a coordinated international response to contain and mitigate the spread of mpox, a virus with significant public health implications.
Mpox, a member of the same viral family as smallpox, is a rare but severe infection. It manifests through symptoms akin to chickenpox, including fevers, swollen …
- Africa CDC has announced an ambitious alliance with vaccine maker Bavarian Nordic to secure 10 million doses of the mpox vaccine by the end of 2025.
- Vaccine maker Bavarian Nordic says it can supply up to 2 million doses by the end of 2024.
- Mpox outbreak has been particularly severe, prompting Africa CDC to declare it a PHECS on August 13, 2024.
In response to the escalating threat of mpox across the Africa, the Africa Centers for Disease Control and Prevention (Africa CDC) has announced an ambitious plan to secure 10 million doses of the mpox vaccine by the end of 2025.
This commitment comes in collaboration with Bavarian Nordic, a leading vaccine manufacturer, which has pledged to ramp up production and ensure the equitable distribution of vaccines.
The initiative is a critical step in tackling the ongoing mpox outbreak, which has been declared a Public Health Emergency of …